Review Article
Functions of Exosomes in the Triangular Relationship between the Tumor, Inflammation, and Immunity in the Tumor Microenvironment
Table 3
Exosomes and immunotherapy.
| Tumor type | Exosome contents | Exosome origin | Effector cells | Active components |
| OSCC | miR-21 | Tumor | MDSCs | PTEN/PD-L1 | CLL | Y RNA hY4 | Tumor | Monocytes | TLR7/CCL2, CCL4, IL-6 | HNSCC | PD-L1(+) | Tumor | CD8+ T cells | CD69 | HCC | PD-1 antibody | Tumor | DCs | PD-1+ CD8+ T cells | | miR-138 | γδ T cell | CD8+ T cells | PD-1, CTLA-4 | | 14-3-3ζ | Tumor | TILs | Cell proliferation | | / | DCs | Naive T cells, CTLs | Cell proliferation | Glioblastoma melanoma | / | NK cells | Tumor cells | TNF-α, granzyme B | Neuroblastoma | miR-186 | NK cells | Tumor cells | MYCN, TGFBR1 |
|
|
Tumor-type abbreviations: OSCC: oral squamous cell carcinoma; HCC: hepatocellular carcinoma; HNSCC: head and neck squamous cell carcinoma; CLL: chronic lymphocytic leukemia. “/” means “not mentioned”.
|